floxuridine has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies
Floxuridine: An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
floxuridine : A pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zhang, N | 1 |
Liang, X | 1 |
Gao, C | 1 |
Chen, M | 1 |
Zhou, Y | 1 |
Krueger, CJ | 1 |
Bao, G | 1 |
Gong, Z | 1 |
Dai, Z | 1 |
1 other study available for floxuridine and ER-Negative PR-Negative HER2-Negative Breast Cancer
Article | Year |
---|---|
Loading Lovastatin into Camptothecin-Floxuridine Conjugate Nanocapsules for Enhancing Anti-metastatic Efficacy of Cocktail Chemotherapy on Triple-negative Breast Cancer.
Topics: Animals; Antineoplastic Agents; Camptothecin; Cell Line, Tumor; Floxuridine; Humans; Lovastatin; Mic | 2018 |